Download PDF

Other users also viewed these articles

Response to ¿Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis¿. Response to related letter José C. De La Flor; Esperanza Moral; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Miguel Rodeles;
Nefrologia (English Version). 2024;44:444-6
Hypochloremia associated with a greater incidence of pneumonia in chronic hemodialysis patients with COVID-19: a center's experience Francisco Valga; Tania Monzón; Nicanor Vega-Diaz; Sergio Ruiz-Santana; Sara Aladro; Rassoul Diallo-Saavedra; Jose Carlos De la Flor; José Carlos Rodriguez-Perez;
Nefrologia (English Version). 2024;44:290-2
Efficacy and safety of semaglutide in a diabetic and obese patient on incremental hemodialysis. Does it also contribute to preserving residual renal function? José Carlos de la Flor; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Elisa Ruiz; Miguel Rodeles;
Nefrologia (English Version). 2023;43:501-3